Headline
The latest stories from AHA Today.
The AHA, California Hospital Association, and Washington State Hospital Association urged the U.S. Court of Appeals for the 9th Circuit to reverse a district court decision in a lawsuit brought by data analysis company Integra Med Analytics that “gives private plaintiffs broad license to file suits…
The Food and Drug Administration and Centers for Disease Control and Prevention July 7 at 12 p.m. ET will host a webinar on decontaminating respirators for health care personnel during the COVID-19 pandemic.
The health care field added 358,000 jobs in June, increasing 2.3% to a seasonally adjusted 15.6 million, the Bureau of Labor Statistics reported.
The blanket data reporting exceptions and extensions implemented in March across Medicare quality reporting and value-based payment programs for hospitals expired July 1.
The House of Representatives voted 233-188 along party lines to pass a $1.5 trillion bill (H.R. 2) introduced by Democratic leaders to rebuild American infrastructure, including roads, bridges, transit, housing and health care.
The House of Representatives passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period through Aug. 8.
The Federal Communications Commission’s Rural Health Care Program will carry forward up to $197.98 million in unused funds from prior years to increase available funding for 2020 to $802.74 million if needed, the agency announced.
Oklahoma voters approved expanding the state’s Medicaid initiative, the first state to do so during the COVID-19 pandemic. The ballot question, which passed with nearly 50.5% of the vote, initiates a state constitutional amendment to provide Medicaid to those with incomes at or below 138% of the…
A bipartisan group of senators introduced the Lifting Our Communities through Advance Liquidity for Infrastructure Act, AHA-supported legislation that would restore tax exemption for advance refunding bonds.
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.